Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Better 8 years late than never: Merck KGaA nabs FDA nod for MS drug Mavenclad

fiercepharmaApril 02, 2019

Tag: Merck KGaA , FDA , MS drug Mavenclad

PharmaSources Customer Service